Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Location
100 Campus Drive,, Suite 102, Florham Park, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 305 % -58.1%
Quick Ratio 3.89 % -4.89%
Debt-to-equity -182 % +44.9%
Return On Equity 77.3 % -63.4%
Return On Assets -94.4 % -2.7%
Operating Margin -145 % +86.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.1M shares +4.04%
Common Stock, Shares, Outstanding 71M shares +3.98%
Entity Public Float 470M USD +138%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 73.4M shares +13.6%
Weighted Average Number of Shares Outstanding, Diluted 73.4M shares +13.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 147M USD +460%
Cost of Revenue 18.8M USD +334%
Research and Development Expense 33.9M USD -12.9%
General and Administrative Expense 91.6M USD +2.05%
Operating Income (Loss) -213M USD +25.9%
Nonoperating Income (Expense) -61.1M USD -18.5%
Net Income (Loss) Attributable to Parent -275M USD +19.1%
Earnings Per Share, Basic -3 USD/shares +34.5%
Earnings Per Share, Diluted -3 USD/shares +34.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 135M USD -59.6%
Inventory, Net 3.61M USD +16.1%
Assets, Current 208M USD -44.4%
Property, Plant and Equipment, Net 1.16M USD -30.2%
Operating Lease, Right-of-Use Asset 2.69M USD +223%
Other Assets, Noncurrent 1.69M USD +0.06%
Assets 240M USD -37.9%
Accounts Payable, Current 1.08M USD -84.9%
Accrued Liabilities, Current 65.3M USD +82.7%
Contract with Customer, Liability, Current 24.3M USD +20.6%
Liabilities, Current 93.1M USD +42.6%
Contract with Customer, Liability, Noncurrent 349M USD +8.25%
Operating Lease, Liability, Noncurrent 2.12M USD
Other Liabilities, Noncurrent 11.5M USD +6.98%
Liabilities 663M USD +15.4%
Retained Earnings (Accumulated Deficit) -1.46B USD -23.1%
Stockholders' Equity Attributable to Parent -423M USD -126%
Liabilities and Equity 240M USD -37.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -84.9M USD -23.1%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -18K USD +55%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 71M shares +3.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -84.9M USD -43.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.23M USD +39.7%
Deferred Tax Assets, Valuation Allowance 255M USD +45.2%
Deferred Tax Assets, Gross 255M USD +45%
Operating Lease, Liability 2.71M USD +299%
Depreciation 500K USD -2.72%
Payments to Acquire Property, Plant, and Equipment 18K USD -55%
Lessee, Operating Lease, Liability, to be Paid 3.79M USD +439%
Property, Plant and Equipment, Gross 4.32M USD +2.98%
Operating Lease, Liability, Current 591K USD -13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 719K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 686K USD +33.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure +72.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.07M USD +4561%
Lessee, Operating Lease, Liability, to be Paid, Year Three 736K USD
Deferred Tax Assets, Operating Loss Carryforwards 195M USD +62.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40M shares 0%
Unrecognized Tax Benefits 3.45M USD +14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 753K USD
Operating Lease, Payments 200K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 177K USD -17.3%
Deferred Tax Assets, Net of Valuation Allowance 150K USD -56.3%
Share-based Payment Arrangement, Expense 29.8M USD -29%
Interest Expense 58.1M USD +54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%